Literature DB >> 25732652

Health-related quality of life in pituitary diseases.

Iris Crespo1, Elena Valassi1, Alicia Santos1, Susan M Webb2.   

Abstract

In the last 15 years, worse health-related quality of life (QoL) has been reported in patients with pituitary diseases compared with healthy individuals. Different QoL questionnaires have shown incomplete physical and psychological recovery after therapy. Residual impairments often affect QoL even long-term after successful treatment of pituitary adenomas. In this article, knowledge of factors that affect QoL in pituitary diseases is reviewed. The focus is on 5 pituitary diseases: Cushing syndrome, acromegaly, prolactinomas, nonfunctioning pituitary adenomas, and hypopituitarism.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acromegaly; Cushing syndrome; Hypopituitarism; Nonfunctioning pituitary adenoma; Pituitary diseases; Prolactinoma; Quality of life

Mesh:

Year:  2014        PMID: 25732652     DOI: 10.1016/j.ecl.2014.10.013

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

Review 2.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

3.  The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.

Authors:  Kenichi Yoshida; Hidenori Fukuoka; Ryusaku Matsumoto; Hironori Bando; Kentaro Suda; Hitoshi Nishizawa; Genzo Iguchi; Wataru Ogawa; Susan M Webb; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

4.  Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas.

Authors:  Rita Indirli; Emanuele Ferrante; Elisa Sala; Claudia Giavoli; Giovanna Mantovani; Maura Arosio
Journal:  Horm Cancer       Date:  2019-04-18       Impact factor: 3.869

5.  Body self-image disturbances in women with prolactinoma.

Authors:  Helen S Pereira; Erika C Naliato; Aline B Moraes; Monica R Gadelha; Leonardo Vieira Neto; Renan M Almeida; Antonio E Nardi; Alice H Violante
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

Review 6.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.

Authors:  Hermann L Müller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.